Mopec Group, the industry leader of anatomic and forensic pathology equipment and technology, today announced a strategic partnership with Lumea, the leader in digital pathology and AI-powered workflow innovation–advancing efficient,…
The digital pathology landscape is evolving at an electrifying pace. As the industry matures, the pathways to tangible value and strategic revenue generation are becoming clearer. A recent article analyzing…
Lumea’s Digital Diagnostic Suite™ (Viewer+™) Receives FDA 510(k) Clearance* for Clinical Diagnosis LEHI, UTAH, UNITED STATES, March 18, 2025 /EINPresswire.com/ – Lumea, a leader in digital pathology solutions, is proud…
Lumea is excited to attend the USCAP 2025 Annual Meeting in Boston, Massachusetts, from March 22-27, 2025. As one of the premier events in pathology, USCAP is where leading minds gather to share insights,…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
